Sumitomo Life Insurance Co. Has $3.01 Million Stake in Morgan Stanley (MS)

Sumitomo Life Insurance Co. lessened its position in Morgan Stanley (NYSE:MS) by 9.3% during the 1st quarter, according to the company in its most recent Form 13F filing with the SEC. The institutional investor owned 71,370 shares of the financial services provider’s stock after selling 7,311 shares during the period. Sumitomo Life Insurance Co.’s holdings in Morgan Stanley were worth $3,012,000 as of its most recent SEC filing.

Several other hedge funds and other institutional investors have also recently modified their holdings of the company. Lowe Brockenbrough & Co. Inc. raised its holdings in shares of Morgan Stanley by 0.6% during the fourth quarter. Lowe Brockenbrough & Co. Inc. now owns 115,414 shares of the financial services provider’s stock valued at $4,576,000 after purchasing an additional 735 shares during the last quarter. Raymond James Financial Services Advisors Inc. raised its holdings in shares of Morgan Stanley by 31.6% during the fourth quarter. Raymond James Financial Services Advisors Inc. now owns 88,206 shares of the financial services provider’s stock valued at $3,497,000 after purchasing an additional 21,173 shares during the last quarter. Springhouse Capital Management LP purchased a new position in shares of Morgan Stanley during the fourth quarter valued at approximately $8,069,000. Morgan Stanley raised its holdings in shares of Morgan Stanley by 6.2% during the third quarter. Morgan Stanley now owns 731,978 shares of the financial services provider’s stock valued at $34,088,000 after purchasing an additional 43,032 shares during the last quarter. Finally, QUANTRES ASSET MANAGEMENT Ltd purchased a new position in shares of Morgan Stanley during the first quarter valued at approximately $827,000. Hedge funds and other institutional investors own 86.10% of the company’s stock.

MS opened at $47.75 on Wednesday. The company has a market capitalization of $77.71 billion, a price-to-earnings ratio of 10.36, a PEG ratio of 1.13 and a beta of 1.19. Morgan Stanley has a 1-year low of $36.74 and a 1-year high of $55.64. The company has a debt-to-equity ratio of 2.60, a current ratio of 0.81 and a quick ratio of 0.81.

Morgan Stanley (NYSE:MS) last posted its quarterly earnings results on Wednesday, April 17th. The financial services provider reported $1.33 earnings per share for the quarter, topping the Zacks’ consensus estimate of $1.17 by $0.16. The business had revenue of $10.29 billion during the quarter, compared to analyst estimates of $9.96 billion. Morgan Stanley had a net margin of 17.43% and a return on equity of 12.02%. The company’s revenue was down 7.1% on a year-over-year basis. During the same period in the prior year, the business posted $1.45 earnings per share. Equities research analysts anticipate that Morgan Stanley will post 4.71 earnings per share for the current fiscal year.

In related news, CFO Paul C. Wirth sold 25,000 shares of the company’s stock in a transaction on Tuesday, February 26th. The shares were sold at an average price of $42.40, for a total transaction of $1,060,000.00. Following the completion of the transaction, the chief financial officer now owns 169,031 shares in the company, valued at $7,166,914.40. The sale was disclosed in a document filed with the SEC, which is available through this hyperlink. Also, insider Jeffrey S. Brodsky sold 15,565 shares of the company’s stock in a transaction on Friday, January 18th. The stock was sold at an average price of $43.38, for a total transaction of $675,209.70. Following the transaction, the insider now owns 112,420 shares of the company’s stock, valued at approximately $4,876,779.60. The disclosure for this sale can be found here. Corporate insiders own 0.19% of the company’s stock.

Several research analysts have recently weighed in on MS shares. HSBC set a $48.00 price objective on shares of Morgan Stanley and gave the company a “neutral” rating in a report on Thursday, April 4th. BMO Capital Markets decreased their price objective on shares of Morgan Stanley to $65.00 and set an “outperform” rating for the company in a report on Friday, January 18th. Wells Fargo & Co raised shares of Morgan Stanley to a “buy ms” rating in a report on Thursday, December 20th. Barclays reduced their target price on shares of Morgan Stanley from $63.00 to $55.00 and set an “equal weight” rating for the company in a report on Wednesday, January 2nd. Finally, Oppenheimer upped their target price on shares of Morgan Stanley from $60.00 to $61.00 and gave the company an “outperform” rating in a report on Tuesday, March 26th. Three investment analysts have rated the stock with a sell rating, six have given a hold rating and nine have given a buy rating to the company. Morgan Stanley presently has an average rating of “Hold” and an average target price of $55.81.

ILLEGAL ACTIVITY WARNING: This piece was first published by Modern Readers and is the property of of Modern Readers. If you are reading this piece on another domain, it was copied illegally and reposted in violation of United States and international copyright & trademark law. The correct version of this piece can be accessed at https://www.modernreaders.com/news/2019/04/17/sumitomo-life-insurance-co-has-3-01-million-stake-in-morgan-stanley-ms.html.

About Morgan Stanley

Morgan Stanley, a financial holding company, provides various financial products and services to corporations, governments, financial institutions, and individuals in the Americas, Europe, the Middle East, Africa, and Asia. The company operates through Institutional Securities, Wealth Management, and Investment Management segments.

Featured Story: How to Profit and Limit Losses With Stop Orders

Want to see what other hedge funds are holding MS? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Morgan Stanley (NYSE:MS).

Institutional Ownership by Quarter for Morgan Stanley (NYSE:MS)

Receive News & Ratings for Morgan Stanley Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Morgan Stanley and related companies with MarketBeat.com's FREE daily email newsletter.